Prognostic performance of a novel multiplex circulating tumor DNA assay for lung cancer outcomes
Therapeutic Advances in Medical Oncology
Published online on August 05, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:Lung cancer is a heterogeneous disease with unpredictable trajectories. Risk stratification in lung cancer remains imprecise within tumor-node-metastasis (TNM) stages.Objectives:This work aims to evaluate whether methylated circulating tumor ...
Background:Lung cancer is a heterogeneous disease with unpredictable trajectories. Risk stratification in lung cancer remains imprecise within tumor-node-metastasis (TNM) stages.Objectives:This work aims to evaluate whether methylated circulating tumor ...